Kurzübersicht für AKR7L Antikörper (AA 207-237) (ABIN6244247)
Target
AKR7L
(Aldo-Keto Reductase Family 7-Like (AKR7L))
Reaktivität
Human, Maus
Wirt
Kaninchen
Klonalität
Polyklonal
Konjugat
Dieser AKR7L Antikörper ist unkonjugiert
Applikation
Western Blotting (WB)
Klon
RB53760
Bindungsspezifität
AA 207-237
Aufreinigung
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This AKR7L antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 207-237 amino acids from the Central region of human AKR7L.
AKR7L
Reaktivität: Human
WB, ELISA
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
WB: 1:2000. WB: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Haltbarkeit
6 months
Target
AKR7L
(Aldo-Keto Reductase Family 7-Like (AKR7L))
Andere Bezeichnung
AKR7L
Hintergrund
Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen (By similarity).